Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study

Author(s):: Fagerli, K.M.; Heijde, D. van der; Heiberg, M.S.; Wierod, A.; Kalstad, S.; Rodevand, E.; Mikkelsen, K.; Kvien, T.K.; Lie, E.

Published: 2014
Publication type: Article / Letter to editor

spondyloarthritisankylosing spondylitistreatmentDMARDsulfasalazineTNF-inhibitor

Date issued: 2014-06-30
Language: English
Is part of: Rheumatology (2014), Vol. 53, no. 6, p. 1087-1094
hdl: 1887/103524
doi: 10.1093/rheumatology/ket450